REPORTS

Let’s Pullulate and Expand Your Business

Hospital-Acquired Diseases Testing Devices Market - Global Professional Analysis and Forecast to 2026

Oct 11, 2019  |  208 PAGES  |  REPORT CODE: CMM204623
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Hospital-Acquired Diseases Testing Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.6% during the forecast period.

This report presents the market size and development trends by detailing the Hospital-Acquired Diseases Testing Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Hospital-Acquired Diseases Testing Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Hospital-Acquired Diseases Testing Devices industry and will help you to build a panoramic view of the industrial development.

Hospital-Acquired Diseases Testing Devices Market, By Type:

  • POC

  • Tissue diagnostic

  • Clinical microbiology

  • Immunodiagnostics

  • Molecular diagnostics

  • Hematology

Hospital-Acquired Diseases Testing Devices Market, By Application:

  • End-Users 1

  • End-Users 2

  • End-Users 3

Some of the leading players are as follows:

  • QIAGEN

  • Cepheid

  • Abbott Laboratories

  • Cantel Medical

  • Meridian Bioscience

  • Gen-Probe

  • Alere

  • Fujirebio/Innogenetics

  • Roche Diagnostics

  • Diatherix Laboratories

  • Akers Biosciences

  • Nordion

  • BioMerieux

  • Enzo Biochem

  • Eiken Chemical

  • Becton and Dickenson

  • Life Technologies

  • Humor Diagnostica

  • Beckman Coulter/Danaher

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Hospital-Acquired Diseases Testing Devices Market: Technology Type Analysis

  • 4.1 Hospital-Acquired Diseases Testing Devices Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Hospital-Acquired Diseases Testing Devices Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 POC

    • 4.3.2 Tissue diagnostic

    • 4.3.3 Clinical microbiology

    • 4.3.4 Immunodiagnostics

    • 4.3.5 Molecular diagnostics

    • 4.3.6 Hematology

5 Hospital-Acquired Diseases Testing Devices Market: Product Analysis

  • 5.1 Hospital-Acquired Diseases Testing Devices Product Market Share Analysis, 2018 & 2026

  • 5.2 Hospital-Acquired Diseases Testing Devices Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Hospital-Acquired Diseases Testing Devices Market: Application Analysis

  • 6.1 Hospital-Acquired Diseases Testing Devices Application Market Share Analysis, 2018 & 2026

  • 6.2 Hospital-Acquired Diseases Testing Devices Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Hospital-Acquired Diseases Testing Devices Market: Regional Analysis

  • 7.1 Hospital-Acquired Diseases Testing Devices Regional Market Share Analysis, 2018 & 2026

  • 7.2 Hospital-Acquired Diseases Testing Devices Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 QIAGEN

    • 9.1.1 QIAGEN Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Cepheid

    • 9.2.1 Cepheid Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Abbott Laboratories

    • 9.3.1 Abbott Laboratories Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Cantel Medical

    • 9.4.1 Cantel Medical Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Meridian Bioscience

    • 9.5.1 Meridian Bioscience Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Gen-Probe

    • 9.6.1 Gen-Probe Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Alere

    • 9.7.1 Alere Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Fujirebio/Innogenetics

    • 9.8.1 Fujirebio/Innogenetics Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Roche Diagnostics

    • 9.9.1 Roche Diagnostics Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Diatherix Laboratories

    • 9.10.1 Diatherix Laboratories Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Akers Biosciences

    • 9.11.1 Akers Biosciences Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Nordion

    • 9.12.1 Nordion Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 BioMerieux

    • 9.13.1 BioMerieux Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Enzo Biochem

    • 9.14.1 Enzo Biochem Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Eiken Chemical

    • 9.15.1 Eiken Chemical Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Becton and Dickenson

    • 9.16.1 Becton and Dickenson Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Life Technologies

    • 9.17.1 Life Technologies Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Humor Diagnostica

    • 9.18.1 Humor Diagnostica Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Beckman Coulter/Danaher

    • 9.19.1 Beckman Coulter/Danaher Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

 

The List of Tables and Figures (Totals 94 Figures and 156 Tables)

  • Figure POC Hospital-Acquired Diseases Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Tissue diagnostic Hospital-Acquired Diseases Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Clinical microbiology Hospital-Acquired Diseases Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Immunodiagnostics Hospital-Acquired Diseases Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Molecular diagnostics Hospital-Acquired Diseases Testing Devices market, 2015 - 2026 (USD Million)

  • Figure Hematology Hospital-Acquired Diseases Testing Devices market, 2015 - 2026 (USD Million)

  • Figure End-Users 1 market, 2015 - 2026 (USD Million)

  • Figure End-Users 2 market, 2015 - 2026 (USD Million)

  • Figure End-Users 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Hospital-Acquired Diseases Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table North America Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table North America Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table North America Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Canada Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Canada Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Europe Hospital-Acquired Diseases Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table Europe Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Europe Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Europe Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Germany Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Germany Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table France Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table France Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Italy Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Italy Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Spain Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Spain Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hospital-Acquired Diseases Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table China Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table China Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Japan Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Japan Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table India Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table India Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Hospital-Acquired Diseases Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table MEA Hospital-Acquired Diseases Testing Devices market, by country, 2015 - 2026 (USD Million)

  • Table MEA Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table MEA Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table MEA Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Hospital-Acquired Diseases Testing Devices market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Hospital-Acquired Diseases Testing Devices market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Hospital-Acquired Diseases Testing Devices market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table QIAGEN Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cepheid Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cantel Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Meridian Bioscience Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Gen-Probe Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alere Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Fujirebio/Innogenetics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Diatherix Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Akers Biosciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nordion Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioMerieux Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Enzo Biochem Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eiken Chemical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Becton and Dickenson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Life Technologies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Humor Diagnostica Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beckman Coulter/Danaher Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top